Diagnostyka SA

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: PLDGNST00012
PLN
175.10
3.1 (1.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
670.92
618.27
612.34
588.30
591.55
505.28
483.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
670.92
618.27
612.34
588.30
591.55
505.28
483.49
Raw Material Cost
544.12
533.29
500.59
477.45
470.39
422.86
397.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
252.32
243.74
233.87
220.84
219.39
199.75
187.42
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
16.92
18.54
17.07
16.43
16.19
14.21
16.27
Selling and Distribution Expenses
3.84
7.32
4.58
5.08
4.08
7.88
0.74
Other Expenses
-26.92
-26.23
-25.09
-23.73
-23.56
-21.40
-20.37
Total Expenditure (Excl Depreciation)
547.96
540.61
505.17
482.53
474.47
430.74
398.53
Operating Profit (PBDIT) excl Other Income
123
77.69999999999999
107.2
105.8
117.10000000000001
74.5
85
Other Income
11.33
-2.54
2.54
4.68
3.05
13.18
3.95
Operating Profit (PBDIT)
181.00
121.18
152.85
153.60
160.03
124.14
122.95
Interest
16.92
18.54
17.07
16.43
16.19
14.21
16.27
Exceptional Items
0.00
-0.23
0.00
-0.34
0.00
0.00
0.00
Gross Profit (PBDT)
126.80
84.98
111.75
110.85
121.16
82.42
85.70
Depreciation
56.56
53.09
51.50
50.12
47.08
43.11
39.89
Profit Before Tax
107.52
49.32
84.29
86.71
96.76
66.83
66.78
Tax
22.16
9.64
3.56
19.77
22.03
10.44
16.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
82.55
36.88
78.06
63.81
72.86
53.77
49.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
82.55
36.88
78.06
63.81
72.86
53.77
49.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.37
2.38
2.69
2.95
2.25
2.18
2.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
85.92
39.26
80.75
66.75
75.11
55.95
51.77
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
604.55
528.40
495.14
420.98
492.25
418.63
387.26
Earnings per share (EPS)
2.45
1.09
2.31
1.89
2.16
1.59
1.47
Diluted Earnings per share
2.45
1.09
2.31
1.89
2.16
1.59
1.47
Operating Profit Margin (Excl OI)
16.86%
11.42%
16.14%
16.79%
18.58%
13.43%
16.36%
Gross Profit Margin
24.46%
16.56%
22.17%
23.26%
24.32%
21.76%
22.06%
PAT Margin
12.3%
5.96%
12.75%
10.85%
12.32%
10.64%
10.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 8.51% vs 0.98% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 118.58% vs -51.30% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 37.19% vs -17.70% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -8.65% vs 8.19% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Diagnostyka SA With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(PLN)
Change(%)
Net Sales
670.92
0
670.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
670.92
0
670.92
Raw Material Cost
544.12
0
544.12
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
252.32
0
252.32
Power Cost
0
0
0.00
Manufacturing Expenses
16.92
0
16.92
Selling and Distribution Expenses
3.84
0
3.84
Other Expenses
-26.92
0.00
-26.92
Total Expenditure (Excl Depreciation)
547.96
0
547.96
Operating Profit (PBDIT) excl Other Income
122.96
0.00
122.96
Other Income
11.33
0
11.33
Operating Profit (PBDIT)
181.00
0
181.00
Interest
16.92
0
16.92
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
126.80
0
126.80
Depreciation
56.56
0
56.56
Profit Before Tax
107.52
0
107.52
Tax
22.16
0
22.16
Provisions and contingencies
0
0
0.00
Profit After Tax
82.55
0
82.55
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
82.55
0
82.55
Share in Profit of Associates
0
0
0.00
Minority Interest
3.37
0
3.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
85.92
0
85.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
604.55
0
604.55
Earnings per share (EPS)
2.45
0
2.45
Diluted Earnings per share
2.45
0
2.45
Operating Profit Margin (Excl OI)
16.86%
0%
0.00
16.86%
Gross Profit Margin
24.46%
0%
0.00
24.46%
PAT Margin
12.30%
0%
0.00
12.30%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 67.09 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.51% vs 0.98% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 13.40% vs 23.12% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.59 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 118.58% vs -51.30% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 14.38% vs 13.27% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.97 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 37.19% vs -17.70% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.09% vs 19.66% in Mar 2025

Quarterly - Interest
Interest 1.69 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.65% vs 8.19% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.32% vs 19.12% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.86%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025